Anduril Valuation Rises 50% to $90 Billion, Exceeding Northrop Grumman
Anduril is valued at $90 billion based on secondary sales, up from a recent $60 billion valuation. That exceeds Northrop Grumman's valuation, is roughly equal to General Dynamics' and about twice L3Harris Technologies'.